Stay updated on Proviral Genotype-Guided ART Clinical Trial

Sign up to get notified when there's something new on the Proviral Genotype-Guided ART Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Proviral Genotype-Guided ART Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a new publication citation for ART-PRO 2020 and removed the 2023 erratum citation; these updates affect publication metadata and do not modify the study design, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-02-05T16:52:42.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Minor UI and labeling updates were made, including the glossary toggle, capitalization changes to QC criteria timestamps, and a new revision version label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T07:27:04.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page, with no changes to study details, eligibility criteria, or primary content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:03:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added the ART-PRO publication (Dolutegravir + lamivudine with the 2023 erratum) and removed the earlier 2020 EBioMedicine citation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-08T01:54:40.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Footer updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T12:20:18.000Z thumbnail image

Stay in the know with updates to Proviral Genotype-Guided ART Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Proviral Genotype-Guided ART Clinical Trial page.